All articles
Hydroquinone Before and After: What Studies Measured Week by Week
Reading time:
13 mins
Skincare

Weeks 5 to 8 usually show the first clear difference
By week 8, the larger trials recorded a clear gap between treated skin and the starting point (10,6). A 2023 narrative review of topical hydroquinone notes that effects should be evident after about 5 to 7 weeks of consistent once-daily use (11).
The largest data set comes from two eight-week trials of the triple cream in 641 adults with moderate to severe melasma. By week 8, 26.1% of people using the triple cream had complete clearing, compared with 4.6% on two-ingredient versions (10). More than 70% of triple-cream users had at least a 75% reduction in pigmentation (10).
Hydroquinone on its own moved more slowly. In the Asian trial, 39.4% of people using 4% hydroquinone twice daily reached a “none” or “mild” grade at week 8, compared with 64.2% on the triple cream (6).
Severity at the start mattered too. On the triple-cream label, 29% of people with moderate melasma cleared by day 56, compared with 16% of those who started out severe (2).
Week 8 is where many before-and-after photos look most convincing. It is also where the FDA-approved triple cream’s studied course ends (2).
Weeks 9 to 12 are where most hydroquinone 4% studies ended
Several single-ingredient 4% hydroquinone trials ran for about 12 weeks (7,12). The 2017 evidence review concluded that hydroquinone’s lightening effect is mostly evident after 8 to 12 weeks (1).
A split-face trial makes this concrete. In a 2003 Brazilian study of 30 people with melasma, one group applied 4% hydroquinone to one side of the face and a placebo cream to the other (12). Treatment lasted three months, with daily SPF 25 sunscreen (12). In that group, the hydroquinone side showed 76.9% improvement compared with placebo, and 25% had side effects (12). Participants had Fitzpatrick skin types IV to VI, and the study ran through summer (12).
The 2013 kojic acid comparison also ended at week 12. By then, 4% hydroquinone showed an overall advantage over the kojic acid cream, which also contained vitamin C (7). The 2017 review noted that difference was not statistically significant in its own analysis, so read it as a trend (1).
Twelve weeks is a reasonable point to judge your own before and after with a provider. The Cleveland Clinic advises contacting your care team if your condition does not improve in the first two months (13).
A week-by-week view of what studies measured
The table below summarizes what each trial visit captured. It reflects the specific products studied, mostly FDA-approved or study-made 4% hydroquinone creams, and does not predict your result.
Time point | What trials measured | Source |
Week 2 | First follow-up visit in some trials, with reactions such as redness and peeling recorded | (6,2) |
Week 4 | Significant MASI drop with 4% hydroquinone; some early clearing | (7,2) |
Week 8 | 26.1% complete clearing on triple cream; 39.4% none or mild on 4% hydroquinone alone | (10,6) |
Week 12 | 76.9% improvement on 4% hydroquinone side vs placebo side | (12) |
6 months after | 53% relapse-free on twice-weekly or tapered triple-cream maintenance | (4) |
Every row above comes from people under study supervision with sunscreen. Real life adds sun, missed nights and other products. Follow your provider’s instructions for how and how long to use any cream.
Combination creams outpaced 4% hydroquinone alone
In head-to-head trials, creams pairing hydroquinone with tretinoin and a mild steroid lightened melasma more than hydroquinone alone. A Cochrane review found the triple-combination cream was significantly more effective than hydroquinone alone, with a risk ratio of 1.58 (8).
That review also found 20% azelaic acid was not significantly more effective than 4% hydroquinone, so hydroquinone is not the only path (8).
These results belong to the specific creams tested, the FDA-approved triple cream and study-made 4% hydroquinone. Compounded formulas are prepared differently and were not tested in these trials, so the timelines above cannot tell you how a compounded cream will perform. For how the two ingredients pair, see hydroquinone and tretinoin. Tretinoin runs on its own clock, covered in tretinoin before and after.
Through Mochi Health, affiliated Mochi Medical providers can evaluate whether a compounded option fits your skin. Two are available: Hydroquinone Brightening Spot Treatment, a compounded topical hydroquinone, and Hydroquinone + Kojic Acid + Tretinoin, a compounded topical combination. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Their use for dark spots and melasma is off-label.
If you want a provider’s view, you can check your eligibility online.
Sunscreen changes the result you end up with
Sun protection is part of every hydroquinone timeline, not an extra. The FDA-approved triple cream’s label pairs treatment with sun avoidance and daily sunscreen of SPF 30 (2), and the split-face and visible-light trials had every participant use sunscreen (12,14).
Visible light matters too. That is the ordinary light you can see, the brightness of a sunny window or an overcast afternoon. In a 2014 double-blind trial, 68 people with melasma used 4% hydroquinone plus either a regular SPF 50 sunscreen or a tinted one with iron oxide, a pigment that absorbs visible light (14).
Among the 61 who finished, the tinted group improved 15% more on MASI score after eight weeks (14). The 2017 review likewise recommends broad-spectrum sunscreen with visible-light protection for melasma (1).
So tint helps. The Cleveland Clinic also advises avoiding sun lamps and tanning beds while you use hydroquinone (13).
Long days in strong sun are worth planning around. Ask your provider how.
Results fade back for many people after stopping
The word “rebound” gets used loosely online. In studies, what you see is relapse: the pigment returns once treatment ends. The FDA-approved triple cream’s label states that melasma usually recurs after treatment is stopped, and that the cream is not indicated for maintenance (2).
Maintenance can stretch the gap. In a 2012 trial, 242 people whose melasma had cleared or become mild after up to eight weeks used the triple cream twice weekly or on a tapering schedule for six months (4). After six months, 53% remained relapse-free, and time to relapse was about 190 days in both groups (4). How severe melasma was at the start predicted relapse (4).
The 2017 review noted that, in one study, relapse followed in almost all cases that improved after 12 weeks of triple-cream treatment (1). The same review set a maximum recommended duration of 16 weeks for 4% hydroquinone (1).
Irritation can also leave its own dark marks, called post-inflammatory hyperpigmentation, which a 2023 review lists as a short-term hydroquinone side effect (11). If your spots look darker after a stretch of stinging, show your provider before changing anything.
Darkening that keeps getting worse can signal ochronosis
Exogenous ochronosis is a rare blue-black or gray-blue darkening that can develop with hydroquinone use. It can look like melasma, so it is easy to miss, and it may worsen as treatment continues (15). The FDA says it may be permanent (3).
A 2022 systematic review pooled 126 published cases. Ochronosis was reported most often in middle-aged women, in people with Fitzpatrick skin types V and VI, and with hydroquinone concentrations above 4% or unknown (5). The median duration of use was five years, and only four cases involved courses of three months or less (5).
The authors concluded that concentrations above 4% and courses longer than three months may be associated with new ochronosis (5). The triple-cream label says most people who develop it are Black, that it can also occur in white and Hispanic patients, and that it should prompt stopping therapy (2).
What does it look like? Lace-like gray-blue or blue-black patches on your face (5). The patches may deepen even as you keep applying cream (15). A 2023 review also lists rare nail discoloration, which typically resolved after stopping (11).
If you notice this pattern, contact your provider promptly.
How to track your own hydroquinone before and after
Your own photos are only useful if they are taken the same way each time. These steps mirror how trials collect images, and they make a follow-up visit far more productive.
Take a baseline photo before your first application, in the same spot, with the same light, no makeup and no filter.
Photograph your face from the front and both sides, since melasma often covers the cheeks and forehead.
Repeat every two weeks, similar to the early visit spacing in some trials (6).
Write down any redness, peeling or burning with the date, because reactions often come before fading (2).
Note your sunscreen use and any long sun exposure, since that can explain a setback (14).
Share the series with your provider around week 8 and again around week 12 (1).
Mirror checks mislead. Lighting changes everything, so the photo series is your real before and after.
Talk to a provider first if you are pregnant or planning to be
Pregnancy is the first thing to raise before you start. The Cleveland Clinic lists being pregnant or trying to get pregnant as something to tell your care team before using hydroquinone (13). The FDA-approved triple cream contains tretinoin, and its label notes that tretinoin is a teratogen, meaning it may harm a developing baby (2).
Other points to share with your provider:
A sulfite allergy or asthma, since the triple cream contains sodium metabisulfite, which can trigger allergic-type reactions (2).
A deeper skin tone or past hydroquinone use, given the ochronosis pattern above and the label’s note that excessive lightening in darker skin cannot be ruled out (5,2).
Any spot that is changing, bleeding or irregular in shape. The dark spots guide explains why those need an in-person exam first.
Other products you use, since the triple-cream label cautions against harsh soaps, astringents and other irritants during treatment (2).
A provider decides whether a hydroquinone cream suits your skin, how often to use it and for how long. Never stretch a course past what your prescriber recommends.
The bottom line
Hydroquinone before and after results in studies were gradual. Some people saw early change by week 4, the clearest difference came between weeks 8 and 12, and combination creams outperformed hydroquinone alone (2,1,8). In the US, hydroquinone is prescription-only, and the only FDA-approved product is a triple-combination cream (3).
Results depended heavily on sunscreen, and melasma usually returned once treatment stopped (14,2). Long, high-strength use has been linked to ochronosis (5). Your provider can help set a timeline, a sun plan and an end point for your course. You can also browse the skincare treatment page to see what is offered.
To see whether a prescription option fits your skin, check your eligibility through Mochi Health.
Frequently asked questions
How long does hydroquinone take to work?
In trials, early lightening sometimes showed by week 4, and most of the visible effect appeared between weeks 8 and 12 (2,1). The Cleveland Clinic advises contacting your care team if your skin has not improved in the first two months (13).
What does hydroquinone 4 before and after look like?
“Hydroquinone 4” usually means 4% hydroquinone. In a split-face trial, the 4% side improved 76.9% over three months compared with placebo (12). In an eight-week Asian trial, 39.4% of people on 4% hydroquinone alone reached a none or mild grade (6).
Why is my skin darker after using hydroquinone?
Irritation can leave post-inflammatory dark marks, and sun exposure can push melasma back (11,14). Rarely, darkening that deepens with ongoing use is ochronosis (5). Contact your provider if your spots darken.
Are hydroquinone results permanent?
Often not. The FDA-approved triple cream’s label says melasma usually recurs after stopping, and in one maintenance trial 53% stayed relapse-free at six months (2,4).
References
Sarma N, Chakraborty S, Poojary SA, et al. Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma (IADVL Special Interest Group on Pigmentary Disorders). Indian Dermatol Online J. 2017;8(6):406-442. PMID: 29204385; PMCID: PMC5707834. https://pmc.ncbi.nlm.nih.gov/articles/PMC5707834/
Galderma Laboratories. TRI-LUMA (fluocinolone acetonide, hydroquinone, and tretinoin) cream, prescribing information. DailyMed, US National Library of Medicine. Revised February 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a35fa709-5eb5-4429-b38f-f1e0019bf0ee
US Food and Drug Administration. FDA works to protect consumers from potentially harmful OTC skin lightening products. Drug Safety Communication, April 19, 2022 (content current as of May 1, 2026). https://www.fda.gov/drugs/drug-safety-communications/fda-works-protect-consumers-potentially-harmful-otc-skin-lightening-products
Arellano I, Cestari T, Ocampo-Candiani J, et al. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity. J Eur Acad Dermatol Venereol. 2012;26(5):611-618. PMID: 21623930. https://pubmed.ncbi.nlm.nih.gov/21623930/
Ishack S, Lipner SR. Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2022;61(6):675-684. PMID: 34486734. https://pubmed.ncbi.nlm.nih.gov/34486734/
Chan R, Park KC, Lee MH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697-703. PMID: 18616780. https://pubmed.ncbi.nlm.nih.gov/18616780/
Monteiro RC, Kishore BN, Bhat RM, et al. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58(2):157. PMID: 23716817; PMCID: PMC3657227. https://pmc.ncbi.nlm.nih.gov/articles/PMC3657227/
Rajaratnam R, Halpern J, Salim A, Emmett C. Interventions for melasma. Cochrane Database Syst Rev. 2010;(7):CD003583. PMID: 20614435. https://pubmed.ncbi.nlm.nih.gov/20614435/
US Food and Drug Administration. Skin Facts! What You Need to Know About Skin Lightening Products. Content current as of May 11, 2026. https://www.fda.gov/consumers/health-fraud-scams/skin-facts-what-you-need-know-about-skin-lightening-products
Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72(1):67-72. PMID: 12889718. https://pubmed.ncbi.nlm.nih.gov/12889718/
Fabian IM, Sinnathamby ES, Flanagan CJ, et al. Topical hydroquinone for hyperpigmentation: a narrative review. Cureus. 2023;15(11):e48840. PMID: 38106810; PMCID: PMC10723018. https://pmc.ncbi.nlm.nih.gov/articles/PMC10723018/
Haddad AL, Matos LF, Brunstein F, et al. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol. 2003;42(2):153-156. PMID: 12709008. https://pubmed.ncbi.nlm.nih.gov/12709008/
Cleveland Clinic. Hydroquinone Skin Cream, Gel, Emulsion, Lotion, or Solution. Cleveland Clinic Health Library (drug information). Accessed November 19, 2026. https://my.clevelandclinic.org/health/drugs/19764-hydroquinone-skin-cream-gel-emulsion-lotion-or-solution
Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35-42. PMID: 24313385. https://pubmed.ncbi.nlm.nih.gov/24313385/
Negassi B, Sit C, Verma KK, et al. Exogenous ochronosis masquerading as melasma in skin of color: indications for early detection and updated clinical review of diagnosis, pathomechanism, and management. Cureus. 2026;18:e115528. PMCID: PMC13626390. https://pmc.ncbi.nlm.nih.gov/articles/PMC13626390/
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Hydroquinone creams, including compounded hydroquinone creams, compounded hydroquinone, kojic acid, and tretinoin creams, and fluocinolone acetonide, hydroquinone, and tretinoin cream (Tri-Luma), require a written prescription from a licensed provider. Speak with a provider to determine if these medications are appropriate for you. Fluocinolone acetonide, hydroquinone, and tretinoin cream (Tri-Luma) is FDA approved for the short-term treatment of moderate to severe melasma of the face. Compounded hydroquinone creams and compounded hydroquinone, kojic acid, and tretinoin creams are not FDA approved, and their use for dark spots and melasma is off-label. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
Share this post
Skincare
More articles





